A study led by University of Michigan School of Public Health and Rogel Cancer Center researchers will describe and quantify the impact of known and suspected environmental exposures on cancer risk.
In two back-to-back, all-day meetings, the FDA Oncologic Drugs Advisory Committee considered four thorny applications that the agency appeared to have been saving up as a result of the pause in activity that followed President Trump’s return to office.
